Legal status · United Kingdom
Is Hydralazine legal in the United Kingdom?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Hydralazine is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.
Hydralazine in the United Kingdom at a glance
| Classification | Licensed, prescription only (MHRA) |
|---|---|
| MHRA approval status | Approved by MHRA for its labeled use |
| Human studies cited | 0 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Hydralazine profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
MHRA has approved Hydralazine for at least one labeled indication, so a pharmaceutical-grade product exists in the United Kingdom and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Hydralazine is
An old blood pressure drug that extended lifespan in worms by activating the same stress pathway as dietary restriction. In mice it did nothing, in either sex.
Hydralazine is a direct vasodilator that has been used for high blood pressure since the 1950s. Its appearance in ageing research came from an unexpected direction: screens in the nematode Caenorhabditis elegans found it extended lifespan and increased stress resistance, working through the worm equivalent of the NRF2 antioxidant response pathway, which is one of the pathways dietary restriction uses.
Mechanism: Two separate mechanisms that should not be confused. Clinically it is a direct arteriolar vasodilator, reducing peripheral resistance and lowering blood pressure, with reflex tachycardia and fluid retention as consequences, which is why it is usually combined with a beta blocker and a diuretic.
Regulatory history: FDA-approved for hypertension, and used in heart failure in combination with isosorbide dinitrate. No ageing indication.
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Hydralazine at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Hydralazine in other countries
Frequently asked questions
Is Hydralazine legal in the United Kingdom?
Yes. Hydralazine is an approved medicine in the United Kingdom, classified as "Licensed, prescription only (MHRA)". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, no human study is cited on its profile.
Can I buy Hydralazine in the United Kingdom?
Only with a prescription. Hydralazine is classified as "Licensed, prescription only (MHRA)" in the United Kingdom, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Hydralazine MHRA approved?
Yes, for its labeled indication. In the United Kingdom Hydralazine is classified as "Licensed, prescription only (MHRA)". For comparison, the US FDA status is: FDA-approved for hypertension, and used in heart failure in combination with isosorbide dinitrate. No ageing indication.. On the evidence, no human study is cited on its profile.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Hydralazine live on its compound profile.
Hydralazine profileThis page is general information about the regulatory status of Hydralazine in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.